Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Long Non-Coding RNAs: Key Regulators of Epithelial-Mesenchymal Transition, Tumour Drug Resistance and Cancer Stem Cells
Richard Heery, Stephen P. Finn, Sinéad Cuffe, et al.
Cancers (2017) Vol. 9, Iss. 4, pp. 38-38
Open Access | Times Cited: 183

Showing 1-25 of 183 citing articles:

lncRNA involvement in cancer stem cell function and epithelial-mesenchymal transitions
Evan M. McCabe, Theodore P. Rasmussen
Seminars in Cancer Biology (2020) Vol. 75, pp. 38-48
Closed Access | Times Cited: 239
Extracellular vesicles and anti-cancer drug resistance
Niamh Mc Namee, Lorraine O’Driscoll
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2018) Vol. 1870, Iss. 2, pp. 123-136
Open Access | Times Cited: 236
Molecular Landscape of LncRNAs in Prostate Cancer: A focus on pathways and therapeutic targets for intervention
Sepideh Mirzaei, Mahshid Deldar Abad Paskeh, Elena Okina, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 126
The Epithelial–Mesenchymal Transition at the Crossroads between Metabolism and Tumor Progression
Monica Fedele, Riccardo Sgarra, Sabrina Battista, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 800-800
Open Access | Times Cited: 119
Knockdown of SOX2OT inhibits the malignant biological behaviors of glioblastoma stem cells via up-regulating the expression of miR-194-5p and miR-122
Rui Su, Shuo Cao, Jun Ma, et al.
Molecular Cancer (2017) Vol. 16, Iss. 1
Open Access | Times Cited: 148
Long noncoding RNAs as regulators of cancer immunity
Nerina Denaro, Marco Merlano, Cristiana Lo Nigro
Molecular Oncology (2018) Vol. 13, Iss. 1, pp. 61-73
Open Access | Times Cited: 138
The emerging role of lncRNAs in inflammatory bowel disease
Reza Yarani, Aashiq H. Mirza, Simranjeet Kaur, et al.
Experimental & Molecular Medicine (2018) Vol. 50, Iss. 12, pp. 1-14
Open Access | Times Cited: 125
LncRNAs as potential diagnostic and prognostic biomarkers in gastric cancer: A novel approach to personalized medicine
Sadegh Fattahi, Mohadeseh Kosari‐Monfared, Monireh Golpour, et al.
Journal of Cellular Physiology (2019) Vol. 235, Iss. 4, pp. 3189-3206
Closed Access | Times Cited: 124
Thyroid cancer stem-like cell exosomes: regulation of EMT via transfer of lncRNAs
Heather Hardin, Holly Helein, Kristy Meyer, et al.
Laboratory Investigation (2018) Vol. 98, Iss. 9, pp. 1133-1142
Open Access | Times Cited: 120
Roles of E-cadherin and Noncoding RNAs in the Epithelial–mesenchymal Transition and Progression in Gastric Cancer
Irina V. Bure, М. В. Немцова, Zaletaev Dv
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 12, pp. 2870-2870
Open Access | Times Cited: 116
ALDH1A3-regulated long non-coding RNA NRAD1 is a potential novel target for triple-negative breast tumors and cancer stem cells
Dejan Vidovic, Thomas T. Huynh, Prathyusha Konda, et al.
Cell Death and Differentiation (2019) Vol. 27, Iss. 1, pp. 363-378
Open Access | Times Cited: 101
Hypoxia-induced alternative splicing: the 11th Hallmark of Cancer
Antonietta R. Farina, Lucia Cappabianca, M. Di Katie Sebastiano, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 96
Non-coding RNA in drug resistance of hepatocellular carcinoma
Bisha Ding, Weiyang Lou, Liang Xu, et al.
Bioscience Reports (2018) Vol. 38, Iss. 5
Open Access | Times Cited: 94
Long noncoding RNA PVT1 promotes EMT via mediating microRNA-186 targeting of Twist1 in prostate cancer
Zhongwen Chang, Jun Cui, Yongsheng Song
Gene (2018) Vol. 654, pp. 36-42
Closed Access | Times Cited: 89
The nuclear hypoxia-regulated NLUCAT1 long non-coding RNA contributes to an aggressive phenotype in lung adenocarcinoma through regulation of oxidative stress
Laura Moreno Leon, Marine Gautier‐Isola, Richard Allan, et al.
Oncogene (2019) Vol. 38, Iss. 46, pp. 7146-7165
Closed Access | Times Cited: 89
Long Noncoding RNA ELIT-1 Acts as a Smad3 Cofactor to Facilitate TGFβ/Smad Signaling and Promote Epithelial–Mesenchymal Transition
Satoshi Sakai, Tatsuya Ohhata, Kyoko Kitagawa, et al.
Cancer Research (2019) Vol. 79, Iss. 11, pp. 2821-2838
Open Access | Times Cited: 86
Long non-coding RNAs and cancer metastasis: Molecular basis and therapeutic implications
Hui Ming, Bowen Li, Li Zhou, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1875, Iss. 2, pp. 188519-188519
Closed Access | Times Cited: 73
Molecular targets, therapeutic agents and multitasking nanoparticles to deal with cancer stem cells: A narrative review
Abolfazl Doustmihan, Marziyeh Fathi, MirAhmad Mazloomi, et al.
Journal of Controlled Release (2023) Vol. 363, pp. 57-83
Open Access | Times Cited: 35
Natural products and long non-coding RNAs in prostate cancer: insights into etiology and treatment resistance
Hanan Elimam, Mohamed Bakr Zaki, Mai A. Abd‐Elmawla, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Open Access | Times Cited: 1
LncRNA‐DANCR contributes to lung adenocarcinoma progression by sponging miR‐496 to modulate mTOR expression
Qingchun Lu, Zhuanghua Rui, Zhongliang Guo, et al.
Journal of Cellular and Molecular Medicine (2017) Vol. 22, Iss. 3, pp. 1527-1537
Open Access | Times Cited: 86
LncRNA SNHG5 regulates imatinib resistance in chronic myeloid leukemia via acting as a CeRNA against MiR-205-5p.
Baoming He, Ying Bai, Wei Kang, et al.
PubMed (2017) Vol. 7, Iss. 8, pp. 1704-1713
Closed Access | Times Cited: 86
Roles of Long Noncoding RNAs in Recurrence and Metastasis of Radiotherapy-Resistant Cancer Stem Cells
Hsiang‐Cheng Chi, Chung‐Ying Tsai, Ming-Ming Tsai, et al.
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 9, pp. 1903-1903
Open Access | Times Cited: 85
Five key lncRNAs considered as prognostic targets for predicting pancreatic ductal adenocarcinoma
Jukun Song, Qiuyan Xu, Haodeng Zhang, et al.
Journal of Cellular Biochemistry (2017) Vol. 119, Iss. 6, pp. 4559-4569
Open Access | Times Cited: 76
Competitive endogenous RNA in colorectal cancer: A systematic review
Shuwen Han, Qing Zhou, Zheng Yan, et al.
Gene (2017) Vol. 645, pp. 157-162
Closed Access | Times Cited: 76
Epithelial-to-Mesenchymal Transition and MicroRNAs in Lung Cancer
Antoine Legras, Nicolas Pécuchet, Sandrine Imbeaud, et al.
Cancers (2017) Vol. 9, Iss. 8, pp. 101-101
Open Access | Times Cited: 72
Page 1 - Next Page

Scroll to top